Open Access

[Retracted] Biochanin A induces anticancer effects in SK‑Mel‑28 human malignant melanoma cells via induction of apoptosis, inhibition of cell invasion and modulation of NF‑κB and MAPK signaling pathways

  • Authors:
    • Peng Xiao
    • Bowen Zheng
    • Jiaming Sun
    • Jia Yang
  • View Affiliations

  • Published online on: April 12, 2021     https://doi.org/10.3892/ol.2021.12724
  • Article Number: 463
  • Copyright : © Xiao et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

June-2021
Volume 21 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xiao P, Zheng B, Sun J and Yang J: [Retracted] Biochanin A induces anticancer effects in SK‑Mel‑28 human malignant melanoma cells via induction of apoptosis, inhibition of cell invasion and modulation of NF‑κB and MAPK signaling pathways. Oncol Lett 21: 463, 2021
APA
Xiao, P., Zheng, B., Sun, J., & Yang, J. (2021). [Retracted] Biochanin A induces anticancer effects in SK‑Mel‑28 human malignant melanoma cells via induction of apoptosis, inhibition of cell invasion and modulation of NF‑κB and MAPK signaling pathways. Oncology Letters, 21, 463. https://doi.org/10.3892/ol.2021.12724
MLA
Xiao, P., Zheng, B., Sun, J., Yang, J."[Retracted] Biochanin A induces anticancer effects in SK‑Mel‑28 human malignant melanoma cells via induction of apoptosis, inhibition of cell invasion and modulation of NF‑κB and MAPK signaling pathways". Oncology Letters 21.6 (2021): 463.
Chicago
Xiao, P., Zheng, B., Sun, J., Yang, J."[Retracted] Biochanin A induces anticancer effects in SK‑Mel‑28 human malignant melanoma cells via induction of apoptosis, inhibition of cell invasion and modulation of NF‑κB and MAPK signaling pathways". Oncology Letters 21, no. 6 (2021): 463. https://doi.org/10.3892/ol.2021.12724